Implantable Cardioverter-Defibrillator Therapy and Implantable Cardioverter-Defibrillator Complications in Idiopathic Ventricular Fibrillation Patients
JACC: Clinical Electrophysiology · 2026-08 · 12 (8) · 1896-1905
DOI: 10.1016/j.jacep.2026.02.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2026-08. Verfasst von Rozan Roodenburg und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: r.roodenburg-3@umcutrecht.nl. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Ventricular Fibrillation. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Hartstichting.
Abstract (Originalsprache)
BACKGROUND: Implantable cardioverter-defibrillator (ICD) therapy is used to prevent sudden cardiac death (SCD) in patients who experienced idiopathic ventricular fibrillation (IVF). Only certain patients with IVF develop recurrence of ventricular arrhythmia (VA). However, all patients with IVF are exposed to the risk of complications. Transvenous ICD (TV-ICD) carries a significant complication risk. The subcutaneous ICD (S-ICD) may offer advantages in this young population. OBJECTIVES: The aim of this study was to analyze ICD therapy in patients with IVF and to assess complications of ICD therapy, comparing S-ICD and TV-ICD. METHODS: Patients were included from the Dutch IVF Registry. First, the occurrence of appropriate ICD therapy (shock/anti-tachycardia pacing) was analyzed. A subgroup was then defined of patients with ICD implantation between 2010 and 2024 to assess inappropriate ICD therapy and other device-related complications. Next, a comparison was made between S-ICD and TV-ICD. RESULTS: Of 415 included patients with IVF, 132 (32%) experienced recurrent VA requiring ICD therapy; subanalysis included 261 patients. There were no significant differences in inappropriate ICD therapy (S-ICD 13% vs TV-ICD 13%; P = 0.976) between S-ICD and TV-ICD. TV-ICD patients had more lead complications compared with S-ICD patients (S-ICD 2% vs TV-ICD 13%; P < 0.001). For the other device-related complications, there were no significant differences between S-ICD and TV-ICD. These results were consistent when corrected for different follow-up duration and age at index event. CONCLUSIONS: VA recurrence occurs frequently, affecting nearly one-third of patients with IVF. Comparing S-ICD and TV-ICD, there were no significant differences in inappropriate ICD therapy. Lead complications were more prevalent with TV-ICD compared with S-ICD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: r.roodenburg-3@umcutrecht.nl.
- Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure & Arrhythmias, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, the Netherlands.
- Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Cardiology, St. Antoniusziekenhuis, Nieuwegein, the Netherlands.
- Department of Cardiology, Thorax Center, Cardiovascular Institute, Erasmus Medical Center, Rotterdam, the Netherlands.
Förderung
- Nederlandse Hartstichting
Zitieren
APA
Roodenburg, R., Verheul, L. M., Hoeksema, W. F., Evertz, R., Balt, J. C., Yap, S. C., Alings, M., Kapel, G. F. L., Bootsma, M., Mulder, B. A., van der Voort, P., Volders, P. G. A., Postema, P. G., Wilde, A. A. M., Meine, M., & Hassink, R. J. (2026). Implantable Cardioverter-Defibrillator Therapy and Implantable Cardioverter-Defibrillator Complications in Idiopathic Ventricular Fibrillation Patients. JACC: Clinical Electrophysiology, 12(8), 1896-1905. https://doi.org/10.1016/j.jacep.2026.02.026
Vancouver
Roodenburg R, Verheul LM, Hoeksema WF, Evertz R, Balt JC, Yap SC, et al. Implantable Cardioverter-Defibrillator Therapy and Implantable Cardioverter-Defibrillator Complications in Idiopathic Ventricular Fibrillation Patients. JACC: Clinical Electrophysiology. 2026;12(8):1896-1905. doi:10.1016/j.jacep.2026.02.026
BibTeX
@article{Roodenburg2026,
author = {Roodenburg, Rozan and Verheul, Lisa M and Hoeksema, Wiert F and Evertz, Reinder and Balt, Jippe C and Yap, Sing Chien and Alings, Marco and Kapel, Gijsbert F L and Bootsma, Marianne and Mulder, Bart A and van der Voort, Pepijn and Volders, Paul G A and Postema, Pieter G and Wilde, Arthur A M and Meine, Mathias and Hassink, Rutger J},
title = {Implantable Cardioverter-Defibrillator Therapy and Implantable Cardioverter-Defibrillator Complications in Idiopathic Ventricular Fibrillation Patients},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
volume = {12},
number = {8},
pages = {1896--1905},
doi = {10.1016/j.jacep.2026.02.026}
}
EUVIMED